Poractant Alfa Medication Information

Learn everything you need to know about Poractant Alfa-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.

Explore Poractant Alfa brand names commonly used in India and internationally, along with detailed pricing information. Consult your healthcare provider for tailored medical advice.

Generic Name : Poractant Alfa

Pronunciation : pore-ACK-tant AL-fuh

Therapeutic Classification : Proteins

Brand Names or Trade Names of Poractant Alfa

International :

Curosurf

Why is Poractant Alfa Prescribed? (Indications)

This medication is a surface-active lipoprotein, prescribed for respiratory distress syndrome (RDS) in premature infants.

When should Poractant Alfa not be taken? (Contraindications)

Contraindicated in patients with anemia, acidity, chills, low blood sugar and hypersensitivity.

What is the dosage of Poractant Alfa?

The initial recommended dose is 2.5 mL/kg birth weight.

How should Poractant Alfa be taken?

It comes as a suspension for intratracheal administration.

What are the warnings and precautions for Poractant Alfa?

• Frequent clinical and laboratory assessments should be given to infants while using this medication.

• Trained and experienced healthcare professionals should only administer it.

• Patient should be treated for anemia, low sugar and chills before the start of the treatment.

What are the side effects of Poractant Alfa?

Complication of premature babies- Slow heart rate, low blood pressure, respiratory blockage and shortness of breath.
Miscellaneous- Pneumonia, stroke, respiratory tract inflammation/infection, sepsis and congenital heart disorder.